ATMA Media Releases

Health Canada Provides a No-Objection Letter to Atma Journey Centers: A Clinical Trial Assessing Psilocybin Safety and Exploring Psychological Outcome in Licensed Medical Practitioners

CALGARY, AB, Jan. 7, 2022 /CNW/ – ATMA Journey Centers Inc. (“ATMA”) has been granted a No Objection Letter (“NOL”) by Health Canada, a crucial step towards opening ATMA’s first sponsored clinical trial. The trial participants are licensed health care providers enrolled in a psychedelic-assisted therapy program. The trial’s primary goal will be to document

Read More »
ATMA News

Our Gratitude and Reflection for 2021

Hello,’Tis the season to sit back and reflect on the year behind us. To be with shorter days and spend time with friends and family.What are you grateful for this past year?At ATMA, it has been quite a year to be grateful. Health Canada has approved dozens of Section 56 Exemptions through many different Doctors,

Read More »
ATMA Media Releases

Working magic?

Mushrooms are having a moment, reports Gayle MacDonald, most notably in the treatment of mental-health disorders and PTSD.

Read More »
ATMA Media Releases

A Bold New Approach to Mental Health

Jonathan Lubecky and Tony White are but a few of the thousands of examples that the impact that Psychedelic-Assisted Therapy can have on those suffering from mental health conditions.

Read More »
Scroll to Top